Announced Fri, 24 Jul · 19:39 IST
Preferential issue funds fully utilized, no deviation reported
Fund Raising View source PDF
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹2055.00
prior close
₹2135.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.4-3.5-2.3-1.0——————————
Up moveDown movePending
AI summary
Neogen Chemicals confirmed full utilization of Rs 161 crore raised through a preferential issue of equity shares in April 2026 with no deviation. Of this, Rs 100 crore went to subsidiary Neogen Ionics for capex at the Pakhanjan project, Rs 21 crore for working capital, and Rs 40 crore for general corporate purposes, with the latter two used to adjust the cash credit facility with SBI. CRISIL Ratings, the monitoring agency, issued the final report for Q1FY27.
Likely market impact
Positive - funds deployed as planned with no deviation, signaling disciplined capital allocation and use of proceeds.